Legend Biotech Corp. (LEGN)
19.80
+0.76
(+3.99%)
USD |
NASDAQ |
Oct 15, 16:00
19.78
-0.02
(-0.10%)
After-Hours: 20:00
Legend Biotech Cash from Operations (TTM) : -182.95M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -182.95M |
| March 31, 2026 | -175.41M |
| December 31, 2025 | -193.81M |
| September 30, 2025 | -170.25M |
| June 30, 2025 | -274.22M |
| March 31, 2025 | -261.29M |
| December 31, 2024 | -141.35M |
| September 30, 2024 | -152.50M |
| June 30, 2024 | -135.94M |
| March 31, 2024 | -227.23M |
| December 31, 2023 | -384.47M |
| September 30, 2023 | -340.01M |
| Date | Value |
|---|---|
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -249.30M |
| December 31, 2021 | -197.35M |
| September 30, 2021 | -184.95M |
| June 30, 2021 | -204.93M |
| March 31, 2021 | -204.15M |
| December 31, 2020 | -223.21M |
| September 30, 2020 | -227.04M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Gilead Sciences, Inc. | 13.55B |
| Ionis Pharmaceuticals, Inc. | -496.43M |
| Johnson & Johnson | -- |
| Arbutus Biopharma Corp. | -24.13M |
| Capricor Therapeutics, Inc. | -104.00M |